ALK inhibitors are highly effective in patients with ALK-rearranged NSCLC.17,18,21,22 Thus, we also examined the effects of ALK inhibitors on RDAA lung cancer cells in vitro and in vivo. The gene discussed is ALK; the disease is lung cancer.